Off-Label Avastin for Wet Macular Degeneration – The Debate Continues

Avastin has been approved as a colon cancer and lung cancer drug.  However, Avastin has been used off-label to treat other cancers and macular degeneration.  The off-label use of Avastin to treat … [Read more...]

Off-Label Avastin Treatment for Macular Degeneration

Avastin, or bevacizumab, has become a popular off-label treatment for wet macular degeneration.  Approved as a colon cancer drug, Avastin has shown to be as effective a treatment for macular … [Read more...]

British Parliament Responds to Macular Degeneration Petition

The British Parliament was presented with a petition from Macular Degeneration Patients stating "We the undersigned petition the Prime Minister to authorise use of all available drugs to combat … [Read more...]

Avastin for Wet Macular Degeneration – Off Label Usage

Avastin (bevacizumab) has become a drug of choice by some opthalmologists for a treatment of wet macular degeneration. Genetech, the company that produces Avastin, would prefer that Lucentis be used … [Read more...]